Jon Mogford
Jon Mogford, PhD, who has an extensive background in biology research and its applications in the field of defense medicine and therapeutics. His expertise includes wound healing/regeneration, cellular therapies, tissue engineering and vascular physiology. His specific interests focus on therapeutics for wounded soldiers, protein design processes and drug delivery. He has authored or co-authored 29 peer-reviewed publications. He served as senior vice president and chief operating office of Texas A&M Health from 2021-2023. He held several roles at the Defense Advanced Research Projects Agency (DARPA) from 2005 to 2011. He co-founded Safi Biotherapuetics in 2019, a company focused on cell therapy, and he served as CEO for SmartPharm Therpuetics, a startup specialzing in RNA therapies.
Latest News
- STEM-Talk: Ask Me Anything with Dr. Ken Ford
- David Bear joins IHMC Board of Directors
- STEM-Talk: Michael Schmidt on building a space-faring civilization
- Florida Blue award supports health and wellness research and outreach at IHMC
- STEM-Talk: Ken Forbus on AI and his development of the Structure Mapping Engine
- STEM-Talk: Pascal Lee on returning to the Moon — and heading to Mars
- Aging Symposium draws experts to IHMC
- IHMC hosts Fredric G. Levin Lung Care Symposium March 27-28 in Pensacola
- Humanoid robotics and exoskeletons lead latest IHMC newsletter